38% of resident physicians think medical marijuana is a prescribed substance, while 78% do not know what category medical cannabis falls within the Controlled Substance Act.
The authors of the research also commented on the need for further research stressing that there is a notable lack of studies and a minimal number of the randomized, controlled trials needed to confirm the effectiveness of any treatment.
Early research from Queen Mary University of London has potentially found an antidote that can rapidly stop the intoxicating effects of cannabis and synthetic cannabinoids.
In a state where cannabis is legal for both medicinal and recreational use, a quarter of patients with cancer believed cannabis helped treat physical and psychological symptoms of their disease.
Despite 29 states legalizing marijuana for medicinal use, few medical students are being trained to prescribe the drug.
The act has been reintroduced to remove regulatory barriers that inhibit researchers from obtaining marijuana plans to conduct studies on medical effectiveness and safety.